Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP006 vs Budesonide/Formoterol in Adults With Asthma
NCT07807007Phase 2Completed
- Sponsor
- Shanghai Xin Huanghe Pharmaceutical
- Start
- Nov 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
A Phase 2 trial of CP006 in asthma, sponsored by Shanghai Xin Huanghe Pharmaceutical. Started Nov 2025; status: completed.
02
Drugs
CP006
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07807007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07807007.